Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia.
about
Christmas disease: a condition previously mistaken for haemophiliaAnimal models of hemophiliaExtravascular FIX and coagulationGenetics of human blood coagulation.Blood coagulation and its alterations in hemorrhagic and thrombotic disordersChristmas disease and coal-mining. Trauma and exposure to nitroglycerine as occupational hazards.Gene therapy for the hemophilias.Comparison of amino acid sequence of bovine coagulation Factor IX (Christmas Factor) with that of other vitamin K-dependent plasma proteinsCharacterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill.The effect of parental age on rates of mutation for hemophilia and evidence for differing mutation rates for hemophilia A and B.Biochemical genetics of blood coagulation.A possible fourth plasma thromboplastin component.A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma.Haemophilia and haemophilic arthropathy. An historical review and a clinical study of 42 cases.A laboratory study of the carrier state in classic hemophilia.Christmas disease; a variant of haemophilia.Nomenclature of blood clotting factors; acceptance by the International Committee on nomenclature of four factors, their characteristics and international number.[THE PROPORTION OF ANTIHEMOPHILIC FACTORS: BIOLOGICAL AND GENETIC CORRELATION WAS DETERMINED ON 55 SUBJECTS].Linkage of color blindness to hemophilias A and B.Studies on the activation of a proesterase associated with partially purified first component of human complementConcerning the Functions and Nomenclature of Blood Clotting FactorsThe history of haemophiliaHaemophilia in Northern Ireland.Surgery in haemophilia and allied disorders.Adeno-associated viral vectors for the treatment of hemophilia.Christmas disease.Haemophilia and related conditions.The two-stage prothrombin assay in study of bleeding and clotting disorders.Characterization of IXINITY® (Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine-148 Polymorph.THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. I. EVIDENCE FOR THE PROPERTIES OF A NEW SERUM THROMBOPLASTIC FACTOR.The effect of glass upon the activity of the various plasma clotting factors.The coagulation of human blood.PTC deficiency with phalangeal and interphalangeal (arthritic) changesSurgery in patients with congenital disorders of blood coagulation.
P2860
Q24569533-6E0724B1-428E-47BA-9A02-5C0FFAFE42BAQ27012571-3397F153-1181-42A3-8F2A-59741DE2A4B0Q28079369-628D12D6-C697-415C-8473-4447D42004E1Q33585242-9CFB89D1-F2F7-4207-820E-710114A723D8Q33606686-2FD96FE4-2E63-4364-83CA-7A763DBB0A6EQ33638636-3C1EA0E4-2779-42A8-80C2-1F6886FFF7BAQ33723486-577AE718-AA19-435B-8E4F-E090CB567119Q34035629-A1539FEC-2066-4C99-BABD-320F933B89F6Q34521511-E7C7B05D-B4C8-4714-8625-F8944FFE9868Q35231697-3F01D3DD-D2DE-4C21-BCF9-D7EFDA6C2FBEQ35252818-785A335D-5FAB-4D48-8A03-6D859D3D646EQ35269578-10AF379B-8D12-45B7-86CC-053E538F16D7Q35282990-3BB88DA4-6C3D-4719-B03D-8E2D35269061Q35342492-4C0F5DA3-0906-4E56-AC46-05F7BDA5C343Q35561906-AB6BE910-9676-48AE-8DF3-8DFCDC0E3353Q35683487-B3800AED-FD73-491B-95D7-6E1EEDA34374Q35693938-54C3582E-D25B-4531-B968-FF4763112AC7Q35904934-3CFA6CD4-7536-458E-AB79-7B9C3C4D0F27Q35912273-02C7ABDD-74BB-43DC-A3F2-A9083B488E71Q36263313-4F3B3DB7-6296-41CE-8F95-80B4D5C0EC8AQ36472267-2F446E9F-D300-4C02-9EE5-EBFA9A6411C2Q36599603-53ED28F1-4828-46A5-9593-F13372180F3AQ36658500-52F8E0B9-A8B8-4E70-A39C-3B6760D5136AQ36664051-D958DDB6-C1AD-4E74-9434-9BD7FABFBD67Q36713767-97967F43-00B3-4FB3-9684-74DA09B00AD9Q36788757-24C86F8D-A542-42FD-AA51-C284EAE9AEDFQ36818622-D6C3F7E1-007E-48E7-B308-4B9376C0E552Q37016309-5BB20D60-3C07-4C7E-89CF-3FC2A6384490Q38796239-31E338BA-0EA0-4E1F-99DC-32432F168A29Q40311337-5A9C63AC-02EF-4A35-B590-653651FF0064Q40993366-0A286AB6-A58E-41AC-93E5-284797166003Q41427004-A5546AB7-4412-4611-ACC2-9C547324B517Q42402272-A918D74E-1777-482B-8AA4-D087732AFC4CQ45877470-622504FE-E96D-487A-8D85-48897DE6CDB0
P2860
Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia.
description
1952 nî lūn-bûn
@nan
1952年の論文
@ja
1952年学术文章
@wuu
1952年学术文章
@zh
1952年学术文章
@zh-cn
1952年学术文章
@zh-hans
1952年学术文章
@zh-my
1952年学术文章
@zh-sg
1952年學術文章
@yue
1952年學術文章
@zh-hant
name
Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia.
@en
Plasma thromboplastin component
@nl
type
label
Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia.
@en
Plasma thromboplastin component
@nl
prefLabel
Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia.
@en
Plasma thromboplastin component
@nl
P2093
P1476
Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia.
@en
P2093
P304
P577
1952-04-01T00:00:00Z